Rovaldi Christopher 4
4 · ACCELERON PHARMA INC · Filed Jan 17, 2018
Insider Transaction Report
Form 4
Rovaldi Christopher
SVP, Program Mgmt and Ops
Transactions
- Sale
Common Stock
2018-01-12$45.00/sh−11,000$495,000→ 24,701 total - Exercise/Conversion
Common Stock
2018-01-12$24.11/sh+11,000$265,210→ 35,701 total - Exercise/Conversion
Option to Purchase Common Stock
2018-01-12−11,000→ 12,000 totalExercise: $24.11Exp: 2023-12-05→ Common Stock (11,000 underlying)
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.